| |
Pre-op
|
3-month FU
|
12-month FU
|
48-month FU
|
Efficacy (%)
|
|---|
|
IMA (degrees)
|
|
Tot. (DS)
|
12.9 (2.8)
|
9.0
|
9.0
|
9.0 (2.0)
|
30.23
|
|
Mild
|
9.1
| | |
7.1
|
22.0
|
|
Moderate
|
12.1
| | |
9.0
|
27.3
|
|
Severe
|
16.6
| | |
10.0
|
39.2
|
|
HVA (degrees)
|
|
Tot.
|
26.4 (6.7)
|
12.3
|
13.1
|
13.9 (6.2)
|
47.35
|
|
Mild
|
16.4
| | |
9.8
|
40.2
|
|
Moderate
|
26.0
| | |
14.2
|
45.0
|
|
Severe
|
32.0
| | |
14.7
|
54.0
|
|
DMAA (degrees)
|
|
Tot.
|
10.12 (4.3)
|
5.0
|
5.2
|
5.4 (3.2)
|
46.64
|
|
Mild
|
6.3
| | |
3.9
|
38.1
|
|
Moderate
|
10.0
| | |
5.3
|
47.0
|
|
Severe
|
12.4
| | |
6.5
|
47.6
|
|
Sesamoid Position (pts)
|
|
Tot.
|
2.4 (0.6)
|
1.1
|
1.2
|
1.3 (0.6)
|
45.83
|
|
Mild
|
2.0
| | |
0.9
|
55.0
|
|
Moderate
|
2.3
| | |
1.3
|
43.5
|
|
Severe
|
2.8
| | |
1.7
|
39.3
|
|
Metatarsal Index
|
|
M1 < M2
|
34
| | |
58
| |
|
M1 = M2
|
28
| | |
19
| |
|
M1 > M2
|
18
| | |
3
| |
|
MTP-I Art. Sup.
|
|
Congruent
|
61
| | |
77
| |
|
Incongruous
|
19
| | |
3
| |
